AMRA and Pfizer form novel research alliance
The companies will evaluate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes. The
Tolerance Bio has signed an agreement securing an exclusive licence from Tanabe Pharma for TLB-33, a clinical-stage anti-IL-33 monoclonal antibody, in a deal that includes potential development and sales milestone payments of up to around $560m.